Human Hepatocytes as a Tool for Studying Toxicity and Drug Metabolism
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Drugs are usually biotransformed into new chemical species that may have either toxic or therapeutic effects. Drug metabolism studies are routinely performed in laboratory animals but, due to metabolic interspecies differences when compared to man, they are not accurate enough to anticipate the metabolic profile of a drug in humans. Human hepatocytes in primary culture provide the closest in vitro model to human liver and the only model that can produce a metabolic profile of a given drug that is very similar to that found in vivo. However their availability is limited due to the restricted access to suitable tissue samples. The scarcity of human liver has led to optimising the cryopreservation of adult hepatocytes for long-term storage and regular supply. Human hepatocytes in primary culture express typical hepatic functions and express drug metabolising enzymes. Moreover, qualitative and quantitative similarities between in vitro and in vivo metabolism of drugs were observed. Different strategies have been envisaged to prolong cell survival and delay the spontaneous decay of the differentiated phenotype during culture. Thus, hepatocytes represent the most appropriate model for the evaluation of integrated drug metabolism, toxicity/metabolism correlations, mechanisms of hepatotoxicity, and the interactions (inhibition and induction) of xenobiotics and drug-metabolising enzymes. However, in view of limitations of primary hepatocytes, efforts are made to develop alternative cellular models (i.e. metabolic competent CYP-engineered cells stably expressing individual CYPs and transient expression of CYPs by transduction of hepatoma cells with recombinant adenoviruses). In summary, several cellular tools are available to address key issues at the earliest stages of drug development for a better candidate selection and hepatotoxicity risk assessment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, liverspecific functions of primary hepatocytes relevant for drug development and toxicity studies are rapidly downregulated during their in vitro cultures [57].”
From A liver-on-a-chip platform with bioprinted hepatic spheroids (2016) · cites this paper as [57]
In the citing paper
“Immortalized cell lines can be used in most research instead of primary cells because they offer several advantages, including cost-effectiveness, ease of use, unlimited availability of materials, and the bypassing of ethical concerns associated with animal and human tissue use [14,15,16].”
From Cell Immortality: In Vitro Effective Techniques to Achieve and Investigate Its Applications and Challenges (2024) · cites this paper as [14]
Citations
Cites
Progress in the reduction, refinement and replacement of animal experimentation
Balls, M., van Zeller, A.-M., & Halder, M. (2000) · DigitalGeorgetown (Georgetown University Library) · Cited by 296
Isolation, Culture and Use of Human Hepatocytes in Drug Research
Gómez-Lechón, M. J., Donato, M. T., Ponsoda, X., Fabra, R., Trullenque, R., & Castell, J. V. (1996) · Elsevier eBooks · doi:10.1016/b978-012163390-5.50007-7 · Cited by 53
Self-citation
Cited by
Items 101–200 of 272
Vicente‐Carrillo, A., Edebert, I., Garside, H., Cotgreave, I. A., Rigler, R. W., Loitto, V. M., Magnusson, K., & Rodríguez‐Martínez, H. (2015) · Toxicology in Vitro · doi:10.1016/j.tiv.2015.01.004 · Cited by 42
Extracellular Matrix Optimization for Enhanced Physiological Relevance in Hepatic Tissue-Chips
Salih, A. R. C., Hyun, K., Asif, A., Soomro, A. M., Farooqi, H. M. U., Kim, Y. S., Kim, K. H., Lee, J. W., Huh, D., & Choi, K. H. (2021) · Polymers · doi:10.3390/polym13173016 · Cited by 40
Jouin, D., Blanchard, N., Alexandre, E., Delobel, F., David‐Pierson, P., Lavé, T., Jaeck, D., Richert, L., & Coassolo, P. (2006) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.01.014 · Cited by 40
Jin, X., Pybus, B. S., Marcsisin, S. R., Logan, T., Luong, T., Sousa, J. C., Matlock, N., Collazo, V. L., Asher, C. O., Carroll, D. W., et al. (2013) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-013-0139-8 · Cited by 40
Carlessi, R., Köhn‐Gaone, J., Olynyk, J. K., & Tirnitz‐Parker, J. E. E. (2019) · Codon Publications eBooks · doi:10.15586/hepatocellularcarcinoma.2019 · Cited by 39
The controlled presentation of TGF-β1 to hepatocytes in a 3D-microfluidic cell culture system
Zhang, C., Chia, S., Ong, S., Zhang, S., Toh, Y., van Noort, D., & Yu, H. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.03.052 · Cited by 37
The use of bioreactors as in vitro models in pharmaceutical research
Ginai, M., Elsby, R., Hewitt, C. J., Surry, D. D., Fenner, K. S., & Coopman, K. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.05.016 · Cited by 36
Thinking outside the liver: Induced pluripotent stem cells for hepatic applications
Rao, M. S., Sasikala, M., & Reddy, D. N. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i22.3385 · Cited by 36
Primary hepatocyte cultures as prominentin vitrotools to study hepatic drug transporters
Ramboer, E., Vanhaecke, T., Rogiers, V., & Vinken, M. (2013) · Drug Metabolism Reviews · doi:10.3109/03602532.2012.756010 · Cited by 34
Upregulation of Krebs cycle and anaerobic glycolysis activity early after onset of liver ischemia
Chan, T. S., Cassim, S., Raymond, V., Gottschalk, S., Merlen, G., Zwingmann, C., Lapierre, P., Darby, P. J., Mazer, C. D., & Bilodeau, M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0199177 · Cited by 34
Inhibitory effect of schisandrin B on free fatty acid-induced steatosis in L-02 cells
Chu, J., Wang, H., Ye, Y., Chan, P., Pan, S.-Y., Fong, W.-F., & Yu, Z. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i19.2379 · Cited by 34
3.9. Toxicokinetics and Metabolism
Coecke, S., Blaauboer, B. J., Elaut, G., Freeman, S. J., Freidig, A. P., Gensmantel, N. P., Hoet, P., Kapoulas, V. M., Ladstetter, B., Langley, G., et al. (2005) · Alternatives to Laboratory Animals · doi:10.1177/026119290503301s15 · Cited by 34
Preapoptotic Cell Stress Response of Primary Hepatocytes
Nipič, D., Pirc, A., Banič, B., Šuput, D., & Milisav, I. (2010) · Hepatology · doi:10.1002/hep.23598 · Cited by 32
Ayed‐Boussema, I., Pascussi, J., Zaied, C., Maurel, P., Bacha, H., & Hassen, W. (2011) · Drug and Chemical Toxicology · doi:10.3109/01480545.2011.589438 · Cited by 31
Characterization of lipid and lipoprotein metabolism in primary human hepatocytes
Ling, J., Lewis, J., Douglas, D. N., Kneteman, N. M., & Vance, D. E. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2012.08.012 · Cited by 30
Development of Murine Cyp3a Knockout Chimeric Mice with Humanized Liver
Kato, K., Ohbuchi, M., Hamamura, S., Ohshita, H., Kazuki, Y., Oshimura, M., Sato, K., Nakada, N., Kawamura, A., Usui, T., et al. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.063479 · Cited by 30
Hewes, J. C., Riddy, D., Morris, R. W., Woodrooffe, A. J., Davidson, B. R., & Fuller, B. J. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.02.015 · Cited by 30
Promises, challenges and future directions of μCCAs
Esch, M. B., Sung, J. H., & Shuler, M. L. (2010) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2010.02.020 · Cited by 29
Aoyama, K., Yoshinari, K., Kim, H., Nagata, K., & Yamazoe, Y. (2009) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.24.209 · Cited by 28
Kowalczyk, M., Piwowarski, J. P., Wardaszka, A., Średnicka, P., Wójcicki, M., & Juszczuk‐Kubiak, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021083 · Cited by 27
Serralta, A. S., Donato, M. T., Martinez, A., Pareja, E., Orbís, F., Castell, J. V., Mir, J., & Gómez-Lechón, M. J. (2005) · Cell Transplantation · doi:10.3727/000000005783982495 · Cited by 27
Self-citationSurendran, S., Raju, S., Kalyani, N., Saini, G., Nandha, J., Bhowmik, H., Rathod, A., Choubey, S. S., Anandamoorthy, B., Sahoo, S. K., et al. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c01879 · Cited by 25
Liu, Y.-L., Lin, L.-C., Tung, Y., Ho, S.-T., Chen, Y.-L., Lin, C., & Wu, J. (2017) · International Journal of Medical Sciences · doi:10.7150/ijms.19553 · Cited by 25
Wang, Y., Zhu, W., Qiu, J. Y., Wang, X., Zhang, P., Yan, J., & Zhou, Z. (2015) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2015.04.006 · Cited by 25
Pang, Y., Montagne, K., Shinohara, M., Komori, K., & Sakai, Y. (2012) · Biofabrication · doi:10.1088/1758-5082/4/4/045004 · Cited by 25
Cell-based models to predict human hepatotoxicity of drugs
Gómez-Lechón, M., Tolosa, L., & Donato, M. T. (2014) · Revista de toxicología · Cited by 23
Self-citationO’Connor, J., Martínez‐Romero, A., Castell, J. V., & Gómez‐Lechón, M. J. (2004) · Cytometry Part A · doi:10.1002/cyto.a.20095 · Cited by 22
Self-citationRamírez, J., Komoroski, B. J., Mirkov, S., Graber, A. Y., Fackenthal, D. L., Schuetz, E. G., Das, S., Ratain, M. J., Innocenti, F., & Strom, S. C. (2006) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000182784.77630.48 · Cited by 22
Satoh, D., Iwado, S., Abe, S., Kazuki, K., Wakuri, S., Oshimura, M., & Kazuki, Y. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187072 · Cited by 21
SIMPLE MACHINE PERFUSION SIGNIFICANTLY ENHANCES HEPATOCYTE YIELDS OF ISCHEMIC AND FRESH RAT LIVERS
Izamis, M., Calhoun, C., Uygun, B. E., Guzzardi, M. A., Price, G. M., Luitje, M. E., Saeidi, N., Yarmush, M. L., & Uygun, K. (2013) · Cell Medicine · doi:10.3727/215517912x658927 · Cited by 20
Doll, M. A., Salazar‐González, R. A., Bodduluri, S., & Hein, D. W. (2017) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2017.05.003 · Cited by 20
Steinbrecht, S., Kammerer, S., & Küpper, J. ‐. (2019) · Journal of Cellular Biotechnology · doi:10.3233/jcb-189013 · Cited by 20
Li, Z., Tang, X., Zhu, L., Qi, X., Cao, G., & Lu, G. (2020) · Environmental Science & Technology · doi:10.1021/acs.est.0c03824 · Cited by 19
Pelechá-Salvador, M., Villanueva-Bádenas, E., Timor-López, E., Donato, M. T., & Tolosa, L. (2021) · Antioxidants · doi:10.3390/antiox11010086 · Cited by 19
Self-citationSato, Y., Sasaki, T., Takahashi, S., Kumagai, T., & Nagata, K. (2015) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3vk5g · Cited by 19
Sanchez-Quant, E., Richter, M., Martinez‐Jimenez, C. P., & Colomé‐Tatché, M. (2022) · Genome biology · doi:10.1016/s0168-8278(22)01138-2 · Cited by 18
Interactions of sesquiterpenes zederone and germacrone with the human cytochrome P450 system
Pimkaew, P., Küblbeck, J., Petsalo, A., Jukka, J., Suksamrarn, A., Juvonen, R. O., Auriola, S. O. K., Piyachaturawat, P., & Honkakoski, P. (2013) · Toxicology in Vitro · doi:10.1016/j.tiv.2013.07.004 · Cited by 18
Sarkar, J., Kumari, J., Tonello, J. M., Kamihira, M., & Kumar, A. (2017) · Biotechnology Journal · doi:10.1002/biot.201700274 · Cited by 18
Schaeffner, I., Petters, J., Aurich, H., Frohberg, P., & Christ, B. (2005) · Assay and Drug Development Technologies · doi:10.1089/adt.2005.3.27 · Cited by 18
Akiyama, S., Saku, N., Miyata, S., Ite, K., Toyoda, M., Kimura, T., Kuroda, M., Nakazawa, A., Kasahara, M., Nonaka, H., et al. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02776-5 · Cited by 17
Stereoselective Toxicity and Metabolism of Lactofen in Primary Hepatocytes From Rat
Wang, X., Diao, J., Shen, Z., Zhu, W., Zhang, P., & Zhou, Z. (2013) · Chirality · doi:10.1002/chir.22207 · Cited by 17
Merlen, G., Raymond, V., Cassim, S., Lapierre, P., & Bilodeau, M. (2019) · Liver Transplantation · doi:10.1002/lt.25415 · Cited by 17
Fay, K. A., Nabb, D. L., Mingoia, R. T., Bischof, I., Nichols, J. W., Segner, H. E., Johanning, K. M., & Han, X. (2015) · Current Protocols in Toxicology · doi:10.1002/0471140856.tx0442s65 · Cited by 17
Wang, Y., Qiu, J. Y., Zhu, W., Wang, X., Zhang, P., Wang, D., & Zhou, Z. (2015) · Chirality · doi:10.1002/chir.22479 · Cited by 17
The Usefulness of Sperm Kinematics in Drug‐Induced Toxicity Assessment
Vicente‐Carrillo, A. (2018) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12994 · Cited by 17
Bonamassa, B., & Liu, D. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.08.005 · Cited by 16
Ranade, A. R., Wilson, M. S., McClanahan, A. M., & Ball, A. J. (2014) · Journal of Toxicology · doi:10.1155/2014/291054 · Cited by 16
TAMH: A Useful In Vitro Model for Assessing Hepatotoxic Mechanisms
Davis, M. J., & Stamper, B. D. (2016) · BioMed Research International · doi:10.1155/2016/4780872 · Cited by 16
Açıkgöz, A., Karim, N., Giri, S., Schmidt‐Heck, W., & Bader, A. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.09.029 · Cited by 16
Slc7a11 stimulates glutathione synthesis to preserve fatty acid metabolism in primary hepatocytes
Liu, Y., Wu, K., Fu, Y., Li, W., & Zhao, X.-Y. (2023) · Redox Report · doi:10.1080/13510002.2023.2260646 · Cited by 15
Allopurinol and 5-aminosalicylic acid influence thiopurine-induced hepatotoxicity in vitro
Broekman, M. M. T. J., Roelofs, H. M. J., Wong, D. R., Kerstholt, M., Leijten, A., Hoentjen, F., Peters, W. H. M., Wanten, G. J. A., & de Jong, D. J. (2015) · Cell Biology and Toxicology · doi:10.1007/s10565-015-9301-1 · Cited by 15
A tryptophan derivative, ITE, enhances liver cell metabolic functions in vitro
Zhang, X., Lü, J., He, B., Tang, L., Liu, X., Zhu, D., Cao, H., Wang, Y., & Li, L. (2016) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2825 · Cited by 15
A functional human liver tissue model: 3D bioprinted co-culture discoids
Subramaniam, V., Abrahan, C. E., Higgins, B., Chisolm, S. J., Sweeney, B., Duraivel, S., Balzano, L., Monjure, T., Wang, C.-Y., Palmer, G. D., et al. (2025) · Biomaterials Advances · doi:10.1016/j.bioadv.2025.214288 · Cited by 14
Marques, L., & Vale, N. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17060747 · Cited by 14
Qiao, S., Feng, S., Wu, Z., He, T., Ma, C., Peng, Z., Tian, E., & Pan, G. (2021) · Drug Metabolism and Disposition · doi:10.1124/dmd.120.000275 · Cited by 14
Detzner, J., Krojnewski, E., Pohlentz, G., Steil, D., Humpf, H., Mellmann, A., Karch, H., & Müthing, J. (2021) · Toxins · doi:10.3390/toxins13020139 · Cited by 14
Whole Zebrafish Cytochrome P450 Assay for Assessing Drug Metabolism and Safety
Li, C., Luo, L., Awerman, J., & McGrath, P. (2011) · Wiley eBooks · doi:10.1002/9781118102138.ch9 · Cited by 14
Douglas, D. N., Kawahara, T., Sis, B., Bond, D., Fischer, K. P., Tyrrell, D. L., Lewis, J. T., & Kneteman, N. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009209 · Cited by 14
Enantioselective metabolism and toxic effects of metalaxyl on primary hepatocytes from rat
Wang, X., Zhu, W., Qiu, J. Y., Zhang, P., Wang, Y., & Zhou, Z. (2016) · Environmental Science and Pollution Research · doi:10.1007/s11356-016-6797-8 · Cited by 13
Introduction to animal tissue culture science
Bhatia, S., Naved, T., & Sardana, S. (2019) · Institute of Physics eBooks · doi:10.1088/2053-2563/aafac0ch1 · Cited by 13
Damelin, L. H., Coward, S. M., Choudhury, S. F., Chalmers, S., Cox, I. J., Robertson, N. J., Revıal, G., Miles, M., Tootle, R., Hodgson, H. J. F., et al. (2004) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2004.09.023 · Cited by 13
Emsen, B., Sadı, G., Bostancı, A., Gursoy, N., Emsen, A., & Aslan, A. (2021) · RENDICONTI LINCEI · doi:10.1007/s12210-021-00976-4 · Cited by 12
Tang, W.-C., Chang, Y.-W., Che, M., Wang, M., Lai, K., Fueger, P. T., Huang, W., Lin, S., & Lai, K. K. Y. (2021) · Current Molecular Pharmacology · doi:10.2174/1874467214666210412144416 · Cited by 12
Bulutoglu, B., Mert, S., Rey-Bedón, C., Deng, S. L., Yarmush, M. L., & Usta, O. B. (2019) · Scientific Reports · doi:10.1038/s41598-019-52174-w · Cited by 12
Immortalization of primary sheep embryo kidney cells
Seridi, N., Hamidouche, M., Belmessabih, N., Kennani, S. E., Gagnon, J., Martinez, G., Coutton, C., Marchal, T., & Chebloune, Y. (2021) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-020-00520-y · Cited by 12
Cellular Reprogramming: A New Technology Frontier in Pharmaceutical Research
Brock, A., Goh, H.-T., Yang, B., Lu, Y., Li, H., & Loh, Y. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0618-z · Cited by 12
Novel emerging cell and organoid systems for the study of drug metabolism and toxicity in humans
Gracey, E. G., & Lampe, J. N. (2025) · Drug Metabolism and Disposition · doi:10.1016/j.dmd.2025.100188 · Cited by 11
Gao, X., Yourick, J. J., & Sprando, R. L. (2023) · The Journal of Toxicological Sciences · doi:10.2131/jts.48.441 · Cited by 11
Metabolism and detection of designer benzodiazepines: a systematic review
Gameli, P. S., HUESTIS, M., Balloni, A., Busardò, F. P., & Carlier, J. (2024) · Drug Metabolism Reviews · doi:10.1080/03602532.2024.2410747 · Cited by 11
Montalbano, M., Curcurù, G., Shirafkan, A., Vento, R., Rastellini, C., & Cicalese, L. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153613 · Cited by 11
Isolation of Nuclei from Flash-frozen Liver Tissue for Single-cell Multiomics
Strzelecki, M., Yin, K., Talavera-López, C. N., & Martinez‐Jimenez, C. P. (2022) · Journal of Visualized Experiments · doi:10.3791/64792-v · Cited by 11
Methods to study mechanisms underlying altered hepatic drug elimination during pregnancy
Jeong, H., & Stika, C. S. (2020) · Seminars in Perinatology · doi:10.1016/j.semperi.2020.151228 · Cited by 11
LIVER TISSUE MODEL FOR DRUG TOXICITY SCREENING
Anene-Nzelu, C. G., Wang, Y., Yu, H., & Leo, H. L. (2011) · Journal of Mechanics in Medicine and Biology · doi:10.1142/s0219519411004083 · Cited by 10
Chen, Y., Pan, J. ‐., Chiang, B., Lu, F. J., & Sheen, L. (2008) · Journal of Food Science · doi:10.1111/j.1750-3841.2008.00884.x · Cited by 10
Jammer, S., Gelman, F., & Lev, O. E. (2016) · Scientific Reports · doi:10.1038/srep23715 · Cited by 9
Gene Expression and Functional Analyses of Primary Rat Hepatocytes on Nanofiber Matrices
Brophy, C. M., Luebke-Wheeler, J. L., Amiot, B. P., Remmel, R. P., Rinaldo, P., & Nyberg, S. L. (2009) · Cells Tissues Organs · doi:10.1159/000223235 · Cited by 9
Saleh, M., Hogeveen, K. N., Fessard, V., & Hégarat, L. L. (2025) · Toxicology · doi:10.1016/j.tox.2025.154280 · Cited by 8
Chen, J., Hua, G., Han, D., Zheng, X., Dong, X., Wang, S., Long, J., Zheng, Z., Wang, A., Wang, J., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-87054-9 · Cited by 8
Decellularized Mouse Liver as a Small-Scale Scaffold for the Creation of a Miniaturized Human Liver
Ijima, H., Fukuda, Y., Uehara, M., Shafiq, M., Wu, F., Cho, J., Sakai, Y., Miyata, T., Yamao, T., Nakao, Y., et al. (2023) · JOURNAL OF CHEMICAL ENGINEERING OF JAPAN · doi:10.1080/00219592.2023.2204899 · Cited by 8
Miranda, C. C., Fernandes, T. G., Diogo, M. M., & Cabral, J. M. S. (2019) · Advances in biochemical engineering, biotechnology · doi:10.1007/10_2019_117 · Cited by 8
Liver Regeneration and Tissue Engineering
Bao, J., Fisher, J. E., & Nyberg, S. L. (2011) · Humana Press eBooks · doi:10.1007/978-1-61779-322-6_17 · Cited by 8
Oral insulin delivery – challenges and strategies
Sonia, T. A., & Sharma, C. P. (2014) · Elsevier eBooks · doi:10.1533/9781908818683.113 · Cited by 8
Differentiation-Promoting Medium Additives for Hepatocyte Cultivation and Cryopreservation
Gouliarmou, V., Pelkonen, O., & Coecke, S. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-2074-7_10 · Cited by 8
Use of in Vitro Data in PBPK Models: An Example of in Vitro to in Vivo Extrapolation with Carbaryl
Yoon, M., Kedderis, G. L., Yang, Y., Allen, B. C., Yan, G. Z., & M.A., H. J. C. I. (2012) · ACS symposium series · doi:10.1021/bk-2012-1099.ch020 · Cited by 8
Vicente‐Carrillo, A. (2016) · Linköping University medical dissertations · doi:10.3384/diss.diva-131862 · Cited by 8
van Noort, D. (2016) · Wiley eBooks · doi:10.1002/9783527683369.ch3 · Cited by 8
Organoids for cell therapy and drug discovery
Miranda, C. C., & Cabral, J. M. S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-819178-1.00045-9 · Cited by 7
Pluta, K. D., Ciężkowska, M., Wisniewska, M. J., Wencel, A., & Pijanowska, D. G. (2021) · Journal of Applied Biomedicine · doi:10.1016/j.bbe.2021.06.005 · Cited by 7
Scientific concepts and applications of integrated discrete multiple organ co-culture technology
Gayathri, L., Dharumadurai, D., & Akbarsha, M. A. (2015) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.4103/0976-500x.155481 · Cited by 7
Vrba, J., Papoušková, B., Lněničková, K., Kosina, P., Křen, V., & Ulrichová, J. (2021) · Antioxidants · doi:10.3390/antiox10060954 · Cited by 6
Role of theN-Acetylation Polymorphism in Solithromycin Metabolism
Hein, D. W., & Doll, M. A. (2017) · Pharmacogenomics · doi:10.2217/pgs-2017-0045 · Cited by 6
New hepatocytes for toxicology?
Härtung, T., & Gribaldo, L. (2004) · Trends in biotechnology · doi:10.1016/j.tibtech.2004.10.010 · Cited by 6
Verhoeven, A., Sanz-Serrano, J., & Vinken, M. (2025) · Archives of Toxicology · doi:10.1007/s00204-025-04235-5 · Cited by 5
Gerdemann, A., Behrens, M., Günther, G., Ghallab, A., Hengstler, J. G., Humpf, H., & Esselen, M. (2025) · Archives of Toxicology · doi:10.1007/s00204-025-04125-w · Cited by 4
Lian, R.-T., Zhuang, A.-Q., Yue, J., Chen, Y., Ma, K., & Wu, Y.-H. (2023) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x18666230125113254 · Cited by 4
Advanced three‐dimensional in vitro liver models to study the activity of anticancer drugs
Żuchowska, A., Frojdenfal, S., Trzaskowski, M., & Jastrzębska, E. (2024) · Biotechnology Journal · doi:10.1002/biot.202400159 · Cited by 4
Leonard, J. A., & Tan, Y. (2019) · Computational Toxicology · doi:10.1016/j.comtox.2019.100101 · Cited by 4
Hirano, T., Hirata, M., Fujimoto, S., Nguyen, N. T., Le, Q. A., Tanihara, F., & Otoi, T. (2020) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-020-00451-8 · Cited by 4
D’Ambrosio, E., Favia, M., Miani, M. G., Pappagallo, F., Mastro, L. D., Ianniello, A., Saltarelli, S., Fiore, M., Napoletano, G., Masellis, R., et al. (2025) · European Psychiatry · doi:10.1192/j.eurpsy.2025.10057 · Cited by 3
Ma, L., Sun, Y., Zhang, B., Tong, Z., Jia, Y., Wang, P., Ou, B., Cao, J., & Huang, G. (2025) · Molecular Diversity · doi:10.1007/s11030-025-11406-0 · Cited by 3
Metadata
- Authors
- Gomez-Lechon, M., Donato, M., Castell, J., & Jover, R.
- Affiliations
- Hospital Universitari i Politècnic La Fe (ES)
- Venue
- Current Drug Metabolism
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2003-08-01
- Volume
- 4
- Issue
- 4
- Pages
- 292-312
- ISSN
- 1389-2002 (ISSN-L)
- OpenAlex
- W2112247582
- Cited by
- 242
- References
- 2
- Citations by year
- 2026: 8 · 2025: 11 · 2024: 5 · 2023: 5 · 2022: 7 · 2021: 18 · 2020: 6 · 2019: 10 · 2018: 8 · 2017: 9 · 2016: 11 · 2015: 14 · 2014: 9 · 2013: 16 · 2012: 12
- FWCI
- 7.47
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Drug Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- human hepatocytes, primary hepatocyte culture, drug metabolism, hepatotoxicity, toxicity prediction, drug-metabolizing enzymes, adenoviral transduction, hepatoma cells, xenobiotic interactions, in vitro-in vivo correlation, drug development
- MeSH terms
- Cells, Cultured, Cytochrome P-450 Enzyme System, Drug Interactions, Pharmaceutical Preparations, Humans, Liver, Models, Biological, Time Factors, Hepatocytes, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.